Form 4: DENTSPLY SIRONA Director Gains RSU Dividends

Sentiment:

Insider Transaction Report


DENTSPLY SIRONA Inc. Director Michael J. Barber acquired 245.816 shares of common stock through RSU dividends, increasing his beneficial ownership.

Summary

  • Michael J. Barber, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 245.816 shares of common stock.
  • The acquisition occurred on January 9, 2026, and was reported on January 13, 2026.
  • These shares represent dividends on previously awarded Restricted Stock Units (RSUs).
  • The newly acquired RSU dividends are subject to the same vesting terms as the underlying RSU awards and vest simultaneously.
  • Each RSU converts to common stock on a 1:1 basis.
  • Following this transaction, Mr. Barber beneficially owns 17,944.987 shares of DENTSPLY SIRONA Inc. common stock.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction (acquisition of RSU dividends) which is a neutral to slightly positive event as it increases director ownership, aligning interests. It does not contain significant positive or negative news impacting the company's operations or financial health.

Positives

  • Increased beneficial ownership by a director, aligning management interests with shareholders.
  • The acquisition is a routine grant of RSU dividends, indicating an ongoing compensation structure.

Future Outlook

The filing indicates the ongoing nature of the company's RSU compensation plan, with future vesting events tied to the underlying awards.

Industry Context

This routine insider transaction reflects standard executive compensation practices within the medical device and dental supply industry, where equity awards like RSUs are common for aligning director interests with long-term company performance.

Comparison to Industry Standards

  • This type of RSU dividend grant is a standard component of executive and director compensation packages across various industries, including healthcare and medical technology.
  • Companies like Johnson & Johnson, Medtronic, and Stryker often utilize similar equity-based incentives to retain talent and align interests, though specific grant sizes and vesting schedules vary.

Stakeholder Impact

  • Shareholders: Increased director ownership may be viewed positively as it aligns management interests with shareholder value.
  • Employees: No direct impact on employees mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

  • The acquired RSU dividends will vest simultaneously with the underlying RSU awards, converting to common stock on a 1:1 basis upon vesting.

Key Dates

DateDescription
01/09/2026Date of transaction where Michael J. Barber acquired shares.
01/13/2026Date the Form 4 was signed and filed.

Recommendation

hold

This Form 4 filing details a routine insider acquisition of shares through RSU dividends, which is a standard compensation practice and does not provide new information that would fundamentally alter the investment thesis for DENTSPLY SIRONA. It indicates continued alignment of director interests with shareholders but offers no operational or financial news to warrant a change in investment recommendation based solely on this filing.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Michael J. Barber, Director, RSU Dividends, Stock Ownership, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.